FDA advisers vote against experimental ALS treatment
WASHINGTON (AP) — Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig's disease at a Sept. 27 meeting prompted by years of patient efforts seeking access to the unproven therapy....
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login